Drastic surges in intracellular reactive oxygen species (ROS) induce cell apoptosis, while most chemotherapy drugs lead to the accumulation of ROS. Here, we constructed an organic compound, arsenical N-(4-(1,3,2-dithiarsinan-2-yl)phenyl)acrylamide (AAZ2), which could prompt the ROS to trigger mitochondrial-dependent apoptosis in gastric cancer (GC). Mechanistically, by targeting pyruvate dehydrogenase kinase 1 (PDK1), AAZ2 caused metabolism alteration and the imbalance of redox homeostasis, followed by the inhibition of phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway and leading to the activation of B-cell lymphoma 2 (Bcl2)/Bcl2-associated X (Bax)/caspase-9 (Cas9)/Cas3 cascades. Importantly, our in vivo data demonstrated that AAZ2 could inhibit the growth of GC xenograft. Overall, our data suggested that AAZ2 could contribute to metabolic abnormalities, leading to mitochondrial-dependent apoptosis by targeting PDK1 in GC.
{"title":"AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer.","authors":"Yi Li, Wenyan She, Xiaoran Xu, Yixin Liu, Xinyu Wang, Sheng Tian, Shiyi Li, Miao Wang, Chaochao Yu, Pan Liu, Tianhe Huang, Yongchang Wei","doi":"10.1631/jzus.B2200351","DOIUrl":"https://doi.org/10.1631/jzus.B2200351","url":null,"abstract":"<p><p>Drastic surges in intracellular reactive oxygen species (ROS) induce cell apoptosis, while most chemotherapy drugs lead to the accumulation of ROS. Here, we constructed an organic compound, arsenical <i>N</i>-(4-(1,3,2-dithiarsinan-2-yl)phenyl)acrylamide (AAZ2), which could prompt the ROS to trigger mitochondrial-dependent apoptosis in gastric cancer (GC). Mechanistically, by targeting pyruvate dehydrogenase kinase 1 (PDK1), AAZ2 caused metabolism alteration and the imbalance of redox homeostasis, followed by the inhibition of phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway and leading to the activation of B-cell lymphoma 2 (Bcl2)/Bcl2-associated X (Bax)/caspase-9 (Cas9)/Cas3 cascades. Importantly, our in vivo data demonstrated that AAZ2 could inhibit the growth of GC xenograft. Overall, our data suggested that AAZ2 could contribute to metabolic abnormalities, leading to mitochondrial-dependent apoptosis by targeting PDK1 in GC.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"232-247"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014317/pdf/JZhejiangUnivSciB-24-3-232.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xinyan Wang, Xiuling Xu, Ting Zhang, Yang Jin, Sheng Xu, Lifeng Chen, Yucheng Lai, Ling Zhang, Ruolang Pan, Yan Yu
Endometrial cancer is the most common gynecological malignancy, affecting up to 3% of women at some point during their lifetime (Morice et al., 2016; Li and Wang, 2021). Based on the pathogenesis and biological behavioral characteristics, endometrial cancer can be divided into estrogen-dependent (I) and non-estrogen-dependent (II) types (Ulrich, 2011). Type I accounts for approximately 80% of cases, of which the majority are endometrioid carcinomas, and the remaining are mucinous adenocarcinomas (Setiawan et al., 2013). It is generally recognized that long-term stimulation by high estrogen levels with the lack of progesterone antagonism is the most important risk factor; meanwhile, there is no definite conclusion on the specific pathogenesis. The incidence of endometrial cancer has been on the rise during the past two decades (Constantine et al., 2019; Gao et al., 2022; Luo et al., 2022). Moreover, the development of assisted reproductive technology and antiprogestin therapy following breast cancer surgery has elevated the risk of developing type I endometrial cancer to a certain extent (Vassard et al., 2019). Therefore, investigating the influence of estrogen in type I endometrial cancer may provide novel concepts for risk assessment and adjuvant therapy, and at the same time, provide a basis for research on new drugs to treat endometrial cancer.
子宫内膜癌是最常见的妇科恶性肿瘤,高达3%的女性在其一生中的某个阶段受到影响(Morice等人,2016;Li and Wang, 2021)。根据发病机制和生物学行为特征,子宫内膜癌可分为雌激素依赖型(estrogen-dependent, I)和非雌激素依赖型(non-estrogen-dependent, II) (Ulrich, 2011)。I型约占80%,其中以子宫内膜样癌居多,其余为粘液腺癌(Setiawan et al., 2013)。人们普遍认为,长期高雌激素水平刺激和缺乏孕酮拮抗作用是最重要的危险因素;同时,具体的发病机制尚无明确的结论。在过去二十年中,子宫内膜癌的发病率一直在上升(Constantine等人,2019;Gao et al., 2022;Luo et al., 2022)。此外,辅助生殖技术的发展和乳腺癌手术后抗黄体酮治疗在一定程度上提高了患I型子宫内膜癌的风险(Vassard et al., 2019)。因此,研究雌激素在I型子宫内膜癌中的影响,可能为风险评估和辅助治疗提供新的思路,同时为研究治疗子宫内膜癌的新药提供依据。
{"title":"Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma.","authors":"Xinyan Wang, Xiuling Xu, Ting Zhang, Yang Jin, Sheng Xu, Lifeng Chen, Yucheng Lai, Ling Zhang, Ruolang Pan, Yan Yu","doi":"10.1631/jzus.B2200436","DOIUrl":"https://doi.org/10.1631/jzus.B2200436","url":null,"abstract":"<p><p>Endometrial cancer is the most common gynecological malignancy, affecting up to 3% of women at some point during their lifetime (Morice et al., 2016; Li and Wang, 2021). Based on the pathogenesis and biological behavioral characteristics, endometrial cancer can be divided into estrogen-dependent (I) and non-estrogen-dependent (II) types (Ulrich, 2011). Type I accounts for approximately 80% of cases, of which the majority are endometrioid carcinomas, and the remaining are mucinous adenocarcinomas (Setiawan et al., 2013). It is generally recognized that long-term stimulation by high estrogen levels with the lack of progesterone antagonism is the most important risk factor; meanwhile, there is no definite conclusion on the specific pathogenesis. The incidence of endometrial cancer has been on the rise during the past two decades (Constantine et al., 2019; Gao et al., 2022; Luo et al., 2022). Moreover, the development of assisted reproductive technology and antiprogestin therapy following breast cancer surgery has elevated the risk of developing type I endometrial cancer to a certain extent (Vassard et al., 2019). Therefore, investigating the influence of estrogen in type I endometrial cancer may provide novel concepts for risk assessment and adjuvant therapy, and at the same time, provide a basis for research on new drugs to treat endometrial cancer.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"262-268"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014318/pdf/JZhejiangUnivSciB-24-3-262.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
北部湾藴育着丰富且亟待研究的海洋(微)生物资源,是活性天然产物的重要来源。本研究从涠洲岛珊瑚共附生构巢裸胞壳菌GXIMD 02509中分离获得一个多硫代二酮哌嗪生物碱和系列芳香聚酮类化合物,包含一个新化合物4a- O -methoxyarugosin H ( 1 )。我们通过采用多种波、光谱学技术及对比文献方法鉴定了化合物的化学结构。化合物 1 ∼ 5 、7和 10 对786-O、SW1990和SW480等3株肿瘤细胞增殖具抑制活性,半抑制浓度(IC_50)值为4.3∼33.4 µmol/L。化合物emestrin J ( 10 )具有一个二硫桥键,还能够显著抑制786-O细胞克隆及迁移,诱导786-O细胞凋亡并阻滞细胞分裂在G2/M期,是一个潜在具抗肿瘤活性的先导化合物。
海洋微生物,特别是海洋真菌,历史上已经证明了它们作为结构新颖和具有药理活性的次级代谢物的丰富来源的价值(Deshmukh等人,2018;Carroll et al., 2022)。珊瑚是生物多样性最高的珊瑚礁的主体,其组织层、骨骼层和黏液层中蕴藏着高度多样化和丰富的微生物共生体,其特定物种的核心成员在空间上划分在珊瑚微栖息地之间(王wq等,2022)。最近发现与珊瑚相关的真菌是结构多样的化合物、萜烯、生物碱、多肽、芳烃、内酯和类固醇的重要生产者。它们具有广泛的生物活性,如抗癌、抗菌和防污活性(Chen et al., 2022)。遗传强大的Emericella属(子囊菌门),有海洋和陆地来源,包括30多种,分布在世界各地。它被认为是具有抗菌活性或细胞毒性的多种次级代谢物的丰富来源(Alburae等,2020)。值得注意的是,最近有报道称,典型生物合成菌株假曲霉(Aspergillus nidulans)的性状态为高度甲基化的聚酮(Li et al., 2019)和含有异吲哚酮的meroterpenoids (Zhou et al., 2016)的重要来源,其骨架异常。
{"title":"An epipolythiodioxopiperazine alkaloid and diversified aromatic polyketides with cytotoxicity from the Beibu Gulf coral-derived fungus <i>Emericella nidulans</i> GXIMD 02509.","authors":"Miaoping Lin, Zhenzhou Tang, Jiaxi Wang, Humu Lu, Chenwei Wang, Yanting Zhang, Xinming Liu, Chenghai Gao, Yonghong Liu, Xiaowei Luo","doi":"10.1631/jzus.B2200622","DOIUrl":"https://doi.org/10.1631/jzus.B2200622","url":null,"abstract":"北部湾藴育着丰富且亟待研究的海洋(微)生物资源,是活性天然产物的重要来源。本研究从涠洲岛珊瑚共附生构巢裸胞壳菌GXIMD 02509中分离获得一个多硫代二酮哌嗪生物碱和系列芳香聚酮类化合物,包含一个新化合物4a- O -methoxyarugosin H ( 1 )。我们通过采用多种波、光谱学技术及对比文献方法鉴定了化合物的化学结构。化合物 1 ∼ 5 、7和 10 对786-O、SW1990和SW480等3株肿瘤细胞增殖具抑制活性,半抑制浓度(IC_50)值为4.3∼33.4 µmol/L。化合物emestrin J ( 10 )具有一个二硫桥键,还能够显著抑制786-O细胞克隆及迁移,诱导786-O细胞凋亡并阻滞细胞分裂在G2/M期,是一个潜在具抗肿瘤活性的先导化合物。","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"275-280"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014321/pdf/JZhejiangUnivSciB-24-3-275.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Guangtao Pan, Ping Zhang, Aiying Chen, Yu Deng, Zhen Zhang, Han Lu, Aoxun Zhu, Cong Zhou, Yanran Wu, Sen Li
Metabolic reprogramming is a common phenomenon in cancer, with aerobic glycolysis being one of its important characteristics. Hypoxia-inducible factor-1α (HIF1Α) is thought to play an important role in aerobic glycolysis. Meanwhile, naringin is a natural flavanone glycoside derived from grapefruits and many other citrus fruits. In this work, we identified glycolytic genes related to HIF1Α by analyzing the colon cancer database. The analysis of extracellular acidification rate and cell function verified the regulatory effects of HIF1Α overexpression on glycolysis, and the proliferation and migration of colon cancer cells. Moreover, naringin was used as an inhibitor of colon cancer cells to illustrate its effect on HIF1Α function. The results showed that the HIF1Α and enolase 2 (ENO2) levels in colon cancer tissues were highly correlated, and their high expression indicated a poor prognosis for colon cancer patients. Mechanistically, HIF1Α directly binds to the DNA promoter region and upregulates the transcription of ENO2; ectopic expression of ENO2 increased aerobic glycolysis in colon cancer cells. Most importantly, we found that the appropriate concentration of naringin inhibited the transcriptional activity of HIF1Α, which in turn decreased aerobic glycolysis in colon cancer cells. Generally, naringin reduces glycolysis in colon cancer cells by reducing the transcriptional activity of HIF1Α and the proliferation and invasion of colon cancer cells. This study helps to elucidate the relationship between colon cancer progression and glucose metabolism, and demonstrates the efficacy of naringin in the treatment of colon cancer.
{"title":"Aerobic glycolysis in colon cancer is repressed by naringin via the <i>HIF1Α</i> pathway.","authors":"Guangtao Pan, Ping Zhang, Aiying Chen, Yu Deng, Zhen Zhang, Han Lu, Aoxun Zhu, Cong Zhou, Yanran Wu, Sen Li","doi":"10.1631/jzus.B2200221","DOIUrl":"https://doi.org/10.1631/jzus.B2200221","url":null,"abstract":"<p><p>Metabolic reprogramming is a common phenomenon in cancer, with aerobic glycolysis being one of its important characteristics. Hypoxia-inducible factor-1α (<i>HIF1Α</i>) is thought to play an important role in aerobic glycolysis. Meanwhile, naringin is a natural flavanone glycoside derived from grapefruits and many other citrus fruits. In this work, we identified glycolytic genes related to <i>HIF1Α</i> by analyzing the colon cancer database. The analysis of extracellular acidification rate and cell function verified the regulatory effects of <i>HIF1Α</i> overexpression on glycolysis, and the proliferation and migration of colon cancer cells. Moreover, naringin was used as an inhibitor of colon cancer cells to illustrate its effect on <i>HIF1Α</i> function. The results showed that the <i>HIF1Α</i> and enolase 2 (<i>ENO2</i>) levels in colon cancer tissues were highly correlated, and their high expression indicated a poor prognosis for colon cancer patients. Mechanistically, <i>HIF1Α</i> directly binds to the DNA promoter region and upregulates the transcription of <i>ENO2</i>; ectopic expression of <i>ENO2</i> increased aerobic glycolysis in colon cancer cells. Most importantly, we found that the appropriate concentration of naringin inhibited the transcriptional activity of <i>HIF1Α</i>, which in turn decreased aerobic glycolysis in colon cancer cells. Generally, naringin reduces glycolysis in colon cancer cells by reducing the transcriptional activity of <i>HIF1Α</i> and the proliferation and invasion of colon cancer cells. This study helps to elucidate the relationship between colon cancer progression and glucose metabolism, and demonstrates the efficacy of naringin in the treatment of colon cancer.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"221-231"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014316/pdf/JZhejiangUnivSciB-24-3-221.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9119361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Meng Yuan, Qian Wu, Mingyang Zhang, Minshan Lai, Wenbo Chen, Jianfeng Yang, Li Jiang, Ji Cao
A series of chemotherapeutic drugs that induce DNA damage, such as cisplatin (DDP), are standard clinical treatments for ovarian cancer, testicular cancer, and other diseases that lack effective targeted drug therapy. Drug resistance is one of the main factors limiting their application. Sensitizers can overcome the drug resistance of tumor cells, thereby enhancing the antitumor activity of chemotherapeutic drugs. In this study, we aimed to identify marketable drugs that could be potential chemotherapy sensitizers and explore the underlying mechanisms. We found that the alcohol withdrawal drug disulfiram (DSF) could significantly enhance the antitumor activity of DDP. JC-1 staining, propidium iodide (PI) staining, and western blotting confirmed that the combination of DSF and DDP could enhance the apoptosis of tumor cells. Subsequent RNA sequencing combined with Gene Set Enrichment Analysis (GSEA) pathway enrichment analysis and cell biology studies such as immunofluorescence suggested an underlying mechanism: DSF makes cells more vulnerable to DNA damage by inhibiting the Fanconi anemia (FA) repair pathway, exerting a sensitizing effect to DNA damaging agents including platinum chemotherapy drugs. Thus, our study illustrated the potential mechanism of action of DSF in enhancing the antitumor effect of DDP. This might provide an effective and safe solution for combating DDP resistance in clinical treatment.
一系列诱导DNA损伤的化疗药物,如顺铂(DDP),是卵巢癌、睾丸癌等缺乏有效靶向药物治疗的疾病的标准临床治疗方法。耐药是限制其应用的主要因素之一。增敏剂可以克服肿瘤细胞的耐药性,从而增强化疗药物的抗肿瘤活性。在这项研究中,我们旨在确定可能成为潜在化疗致敏剂的上市药物并探索其潜在机制。我们发现酒精戒断药双硫仑(DSF)能显著增强DDP的抗肿瘤活性。JC-1染色、碘化丙啶(PI)染色、western blotting均证实DSF与DDP联合使用可促进肿瘤细胞凋亡。随后的RNA测序结合基因集富集分析(Gene Set Enrichment Analysis, GSEA)通路富集分析和免疫荧光等细胞生物学研究提示其潜在机制:DSF通过抑制Fanconi贫血(FA)修复通路,使细胞更容易受到DNA损伤,对铂类化疗药物等DNA损伤剂产生增敏作用。因此,我们的研究阐明了DSF增强DDP抗肿瘤作用的潜在作用机制。这可能为临床治疗抗DDP耐药提供一种有效、安全的解决方案。
{"title":"Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.","authors":"Meng Yuan, Qian Wu, Mingyang Zhang, Minshan Lai, Wenbo Chen, Jianfeng Yang, Li Jiang, Ji Cao","doi":"10.1631/jzus.B2200405","DOIUrl":"https://doi.org/10.1631/jzus.B2200405","url":null,"abstract":"<p><p>A series of chemotherapeutic drugs that induce DNA damage, such as cisplatin (DDP), are standard clinical treatments for ovarian cancer, testicular cancer, and other diseases that lack effective targeted drug therapy. Drug resistance is one of the main factors limiting their application. Sensitizers can overcome the drug resistance of tumor cells, thereby enhancing the antitumor activity of chemotherapeutic drugs. In this study, we aimed to identify marketable drugs that could be potential chemotherapy sensitizers and explore the underlying mechanisms. We found that the alcohol withdrawal drug disulfiram (DSF) could significantly enhance the antitumor activity of DDP. JC-1 staining, propidium iodide (PI) staining, and western blotting confirmed that the combination of DSF and DDP could enhance the apoptosis of tumor cells. Subsequent RNA sequencing combined with Gene Set Enrichment Analysis (GSEA) pathway enrichment analysis and cell biology studies such as immunofluorescence suggested an underlying mechanism: DSF makes cells more vulnerable to DNA damage by inhibiting the Fanconi anemia (FA) repair pathway, exerting a sensitizing effect to DNA damaging agents including platinum chemotherapy drugs. Thus, our study illustrated the potential mechanism of action of DSF in enhancing the antitumor effect of DDP. This might provide an effective and safe solution for combating DDP resistance in clinical treatment.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"207-220"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014319/pdf/JZhejiangUnivSciB-24-3-207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Polymyxin B, which is a last-line antibiotic for extensively drug-resistant Gram-negative bacterial infections, became available in China in Dec. 2017. As dose adjustments are based solely on clinical experience of risk toxicity, treatment failure, and emergence of resistance, there is an urgent clinical need to perform therapeutic drug monitoring (TDM) to optimize the use of polymyxin B. It is thus necessary to standardize operating procedures to ensure the accuracy of TDM and provide evidence for their rational use. We report a consensus on TDM guidelines for polymyxin B, as endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society. The consensus panel was composed of clinicians, pharmacists, and microbiologists from different provinces in China and Australia who made recommendations regarding target concentrations, sample collection, reporting, and explanation of TDM results. The guidelines provide the first-ever consensus on conducting TDM of polymyxin B, and are intended to guide optimal clinical use.
{"title":"Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society.","authors":"Xiaofen Liu, Chenrong Huang, Phillip J Bergen, Jian Li, Jingjing Zhang, Yijian Chen, Yongchuan Chen, Beining Guo, Fupin Hu, Jinfang Hu, Linlin Hu, Xin Li, Hongqiang Qiu, Hua Shao, Tongwen Sun, Yu Wang, Ping Xu, Jing Yang, Yong Yang, Zhenwei Yu, Bikui Zhang, Huaijun Zhu, Xiaocong Zuo, Yi Zhang, Liyan Miao, Jing Zhang","doi":"10.1631/jzus.B2200466","DOIUrl":"https://doi.org/10.1631/jzus.B2200466","url":null,"abstract":"<p><p>Polymyxin B, which is a last-line antibiotic for extensively drug-resistant Gram-negative bacterial infections, became available in China in Dec. 2017. As dose adjustments are based solely on clinical experience of risk toxicity, treatment failure, and emergence of resistance, there is an urgent clinical need to perform therapeutic drug monitoring (TDM) to optimize the use of polymyxin B. It is thus necessary to standardize operating procedures to ensure the accuracy of TDM and provide evidence for their rational use. We report a consensus on TDM guidelines for polymyxin B, as endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society. The consensus panel was composed of clinicians, pharmacists, and microbiologists from different provinces in China and Australia who made recommendations regarding target concentrations, sample collection, reporting, and explanation of TDM results. The guidelines provide the first-ever consensus on conducting TDM of polymyxin B, and are intended to guide optimal clinical use.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"130-142"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260281/pdf/JZhejiangUnivSciB-24-2-130.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Given its state of stable proliferative inhibition, cellular senescence is primarily depicted as a critical mechanism by which organisms delay the progression of carcinogenesis. Cells undergoing senescence are often associated with the alteration of a series of specific features and functions, such as metabolic shifts, stemness induction, and microenvironment remodeling. However, recent research has revealed more complexity associated with senescence, including adverse effects on both physiological and pathological processes. How organisms evade these harmful consequences and survive has become an urgent research issue. Several therapeutic strategies targeting senescence, including senolytics, senomorphics, immunotherapy, and function restoration, have achieved initial success in certain scenarios. In this review, we describe in detail the characteristic changes associated with cellular senescence and summarize currently available countermeasures.
{"title":"Multiple characteristic alterations and available therapeutic strategies of cellular senescence.","authors":"Yunzi Zhao, Hui Li, Qinglong Guo, Hui Hui","doi":"10.1631/jzus.B2200178","DOIUrl":"https://doi.org/10.1631/jzus.B2200178","url":null,"abstract":"<p><p>Given its state of stable proliferative inhibition, cellular senescence is primarily depicted as a critical mechanism by which organisms delay the progression of carcinogenesis. Cells undergoing senescence are often associated with the alteration of a series of specific features and functions, such as metabolic shifts, stemness induction, and microenvironment remodeling. However, recent research has revealed more complexity associated with senescence, including adverse effects on both physiological and pathological processes. How organisms evade these harmful consequences and survive has become an urgent research issue. Several therapeutic strategies targeting senescence, including senolytics, senomorphics, immunotherapy, and function restoration, have achieved initial success in certain scenarios. In this review, we describe in detail the characteristic changes associated with cellular senescence and summarize currently available countermeasures.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"101-114"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9615425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sepsis is a complex syndrome caused by multiple pathogens and involves multiple organ failure, particularly spleen dysfunction. In 2017, the worldwide incidence was 48.9 million sepsis cases and 11 million sepsis-related deaths were reported (Rudd et al., 2020). Inflammation, oxidative stress, and apoptosis are the most common pathologies seen in sepsis. Liensinine (LIE) is a bisbenzylisoquinoline-type alkaloid extracted from the seed embryo of Nelumbo nucifera. Lotus seed hearts have high content of LIE which mainly has antihypertensive and antiarrhythmic pharmacological effects. It can exert anti-carcinogenic activity by regulating cell, inflammation, and apoptosis signaling pathways (Manogaran et al., 2019). However, its protective effect from sepsis-induced spleen damage is unknown. In this research, we established a mouse sepsis model induced by lipopolysaccharide (LPS) and investigated the protective effects of LIE on sepsis spleen injury in terms of inflammatory response, oxidative stress, and apoptosis.
脓毒症是一种由多种病原体引起的复杂综合征,涉及多器官功能衰竭,尤其是脾功能障碍。2017年,全球脓毒症发病率为4890万例,报告了1100万例脓毒症相关死亡(Rudd et al., 2020)。炎症、氧化应激和细胞凋亡是脓毒症最常见的病理。莲子碱是一种从莲子胚中提取的双苄基异喹啉类生物碱。莲子心含有高含量的LIE,主要具有抗高血压和抗心律失常的药理作用。它可以通过调节细胞、炎症和凋亡信号通路发挥抗癌活性(Manogaran et al., 2019)。然而,其对败血症引起的脾损伤的保护作用尚不清楚。本研究通过建立脂多糖(LPS)诱导的小鼠脓毒症模型,从炎症反应、氧化应激、细胞凋亡等方面研究LIE对脓毒症脾损伤的保护作用。
{"title":"Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model.","authors":"Hanyu Wang, Yuanhao Yang, Xiao Zhang, Yan Wang, Hui Fan, Jinfeng Shi, Xuelian Tan, Baoshi Xu, Jingchao Qiang, Enzhuang Pan, Mingyi Chu, Zibo Dong, Jingquan Dong","doi":"10.1631/jzus.B2200340","DOIUrl":"https://doi.org/10.1631/jzus.B2200340","url":null,"abstract":"<p><p>Sepsis is a complex syndrome caused by multiple pathogens and involves multiple organ failure, particularly spleen dysfunction. In 2017, the worldwide incidence was 48.9 million sepsis cases and 11 million sepsis-related deaths were reported (Rudd et al., 2020). Inflammation, oxidative stress, and apoptosis are the most common pathologies seen in sepsis. Liensinine (LIE) is a bisbenzylisoquinoline-type alkaloid extracted from the seed embryo of Nelumbo nucifera. Lotus seed hearts have high content of LIE which mainly has antihypertensive and antiarrhythmic pharmacological effects. It can exert anti-carcinogenic activity by regulating cell, inflammation, and apoptosis signaling pathways (Manogaran et al., 2019). However, its protective effect from sepsis-induced spleen damage is unknown. In this research, we established a mouse sepsis model induced by lipopolysaccharide (LPS) and investigated the protective effects of LIE on sepsis spleen injury in terms of inflammatory response, oxidative stress, and apoptosis.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"185-190"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260283/pdf/JZhejiangUnivSciB-24-2-185.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9979139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function. ANSD represents up to 15% of individuals with hearing impairments. Through mutation screening, bioinformatic analysis and expression studies, we have previously identified several apoptosis-inducing factor (AIF) mitochondria-associated 1 (AIFM1) variants in ANSD families and in some other sporadic cases. Here, to elucidate the pathogenic mechanisms underlying each AIFM1 variant, we generated AIF-null cells using the clustered regularly interspersed short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system and constructed AIF-wild type (WT) and AIF-mutant (mut) (p.T260A, p.R422W, and p.R451Q) stable transfection cell lines. We then analyzed AIF structure, coenzyme-binding affinity, apoptosis, and other aspects. Results revealed that these variants resulted in impaired dimerization, compromising AIF function. The reduction reaction of AIF variants had proceeded slower than that of AIF-WT. The average levels of AIF dimerization in AIF variant cells were only 34.5%‒49.7% of that of AIF-WT cells, resulting in caspase-independent apoptosis. The average percentage of apoptotic cells in the variants was 12.3%‒17.9%, which was significantly higher than that (6.9%‒7.4%) in controls. However, nicotinamide adenine dinucleotide (NADH) treatment promoted the reduction of apoptosis by rescuing AIF dimerization in AIF variant cells. Our findings show that the impairment of AIF dimerization by AIFM1 variants causes apoptosis contributing to ANSD, and introduce NADH as a potential drug for ANSD treatment. Our results help elucidate the mechanisms of ANSD and may lead to the provision of novel therapies.
{"title":"<i>AIFM1</i> variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization.","authors":"Yue Qiu, Hongyang Wang, Huaye Pan, Jing Guan, Lei Yan, Mingjie Fan, Hui Zhou, Xuanhao Zhou, Kaiwen Wu, Zexiao Jia, Qianqian Zhuang, Zhaoying Lei, Mengyao Li, Xue Ding, Aifu Lin, Yong Fu, Dong Zhang, Qiuju Wang, Qingfeng Yan","doi":"10.1631/jzus.B2200081","DOIUrl":"https://doi.org/10.1631/jzus.B2200081","url":null,"abstract":"<p><p>Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function. ANSD represents up to 15% of individuals with hearing impairments. Through mutation screening, bioinformatic analysis and expression studies, we have previously identified several apoptosis-inducing factor (AIF) mitochondria-associated 1 (<i>AIFM1</i>) variants in ANSD families and in some other sporadic cases. Here, to elucidate the pathogenic mechanisms underlying each <i>AIFM1</i> variant, we generated AIF-null cells using the clustered regularly interspersed short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system and constructed AIF-wild type (WT) and AIF-mutant (mut) (p.T260A, p.R422W, and p.R451Q) stable transfection cell lines. We then analyzed AIF structure, coenzyme-binding affinity, apoptosis, and other aspects. Results revealed that these variants resulted in impaired dimerization, compromising AIF function. The reduction reaction of AIF variants had proceeded slower than that of AIF-WT. The average levels of AIF dimerization in AIF variant cells were only 34.5%‒49.7% of that of AIF-WT cells, resulting in caspase-independent apoptosis. The average percentage of apoptotic cells in the variants was 12.3%‒17.9%, which was significantly higher than that (6.9%‒7.4%) in controls. However, nicotinamide adenine dinucleotide (NADH) treatment promoted the reduction of apoptosis by rescuing AIF dimerization in AIF variant cells. Our findings show that the impairment of AIF dimerization by <i>AIFM1</i> variants causes apoptosis contributing to ANSD, and introduce NADH as a potential drug for ANSD treatment. Our results help elucidate the mechanisms of ANSD and may lead to the provision of novel therapies.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"172-184"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260280/pdf/JZhejiangUnivSciB-24-2-172.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuzhu Xu, Pan Fan, Lei Liu, X U Xuanfei, Lele Zhang, Jiadong Wang, Yuao Tao, Xiaolong Li, Xi Li, Yuntao Wang
Ex vivo culture-amplified mesenchymal stem cells (MSCs) have been studied because of their capacity for healing tissue injury. MSC transplantation is a valid approach for promoting the repair of damaged tissues and replacement of lost cells or to safeguard surviving cells, but currently the efficiency of MSC transplantation is constrained by the extensive loss of MSCs during the short post-transplantation period. Hence, strategies to increase the efficacy of MSC treatment are urgently needed. Iron overload, reactive oxygen species deposition, and decreased antioxidant capacity suppress the proliferation and regeneration of MSCs, thereby hastening cell death. Notably, oxidative stress (OS) and deficient antioxidant defense induced by iron overload can result in ferroptosis. Ferroptosis may inhibit cell survival after MSC transplantation, thereby reducing clinical efficacy. In this review, we explore the role of ferroptosis in MSC performance. Given that little research has focused on ferroptosis in transplanted MSCs, further study is urgently needed to enhance the in vivo implantation, function, and duration of MSCs.
{"title":"Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway.","authors":"Yuzhu Xu, Pan Fan, Lei Liu, X U Xuanfei, Lele Zhang, Jiadong Wang, Yuao Tao, Xiaolong Li, Xi Li, Yuntao Wang","doi":"10.1631/jzus.B2200410","DOIUrl":"https://doi.org/10.1631/jzus.B2200410","url":null,"abstract":"<p><p>Ex vivo culture-amplified mesenchymal stem cells (MSCs) have been studied because of their capacity for healing tissue injury. MSC transplantation is a valid approach for promoting the repair of damaged tissues and replacement of lost cells or to safeguard surviving cells, but currently the efficiency of MSC transplantation is constrained by the extensive loss of MSCs during the short post-transplantation period. Hence, strategies to increase the efficacy of MSC treatment are urgently needed. Iron overload, reactive oxygen species deposition, and decreased antioxidant capacity suppress the proliferation and regeneration of MSCs, thereby hastening cell death. Notably, oxidative stress (OS) and deficient antioxidant defense induced by iron overload can result in ferroptosis. Ferroptosis may inhibit cell survival after MSC transplantation, thereby reducing clinical efficacy. In this review, we explore the role of ferroptosis in MSC performance. Given that little research has focused on ferroptosis in transplanted MSCs, further study is urgently needed to enhance the in vivo implantation, function, and duration of MSCs.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"115-129"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260286/pdf/JZhejiangUnivSciB-24-2-115.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}